- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Raymond Meng appointed as sales director for China
Innovalight, Inc., a privately-held company selling silicon ink and advanced solar cell process technology, today announced the opening of a sales and support office in Shanghai, China.
The office will handle sales and technical support for Innovalight's customers throughout China and will be managed by Raymond Meng, Innovalight's recently appointed sales director for China.
"We are expanding our presence in China and need to be closer to our customers," said Boris Mathiszik, vice president of worldwide sales for Innovalight. "We are experiencing ever increasing demand from crystalline silicon solar cell manufacturers in the region," he added.
Innovalight's sales office is located on Ding Xiang Road in Pudong, Shanghai, Telephone: +86-13916976420.
Innovalight manufactures a proprietary nanotechnology-based silicon ink and licenses a proprietary platform process which allows for a simple upgrade to solar cell manufacturing production lines to boost performance of solar cells and lower production costs.
Innovalight recently announced commercial agreements in China with JA Solar Holdings Co., Ltd., (Nasdaq:JASO), and Yingli Green Energy Holding Company Limited (NYSE: YGE).
Innovalight is based in Sunnyvale, California. The company manufactures silicon ink and licenses a proprietary process technology to solar cell manufacturing companies. Innovalight is venture capital backed and has received additional development funds from the U.S. Dept. of Energy.
For more information, please click here
Copyright © InnovalightIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Blue Star Opportunities Corp. (BSTO) Completes Major Condo Building Project in Manhattan Residential Area; Company Now Has the Resources to Service the Largest of Construction Projects April 21st, 2015
DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015
Haydale Announce Dedicated Graphene Inks Manufacturing Capability March 25th, 2015
LamdaGen Corporation Launches Taiwan Diagnostic Subsidiary March 19th, 2015